# Convalescent Plasma Trial in COVID -19 Patients

> **NCT04356534** · NA · COMPLETED · sponsor: **Royal College of Surgeons in Ireland - Medical University of Bahrain** · enrollment: 40 (actual)

## Conditions studied

- SARS-CoV 2
- COVID-19

## Interventions

- **OTHER:** plasma therapy using convalescent plasma with antibody against SARS-CoV-2
- **OTHER:** Routine care for COVID-19 patients

## Key facts

- **NCT ID:** NCT04356534
- **Lead sponsor:** Royal College of Surgeons in Ireland - Medical University of Bahrain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-19
- **Primary completion:** 2020-06-15
- **Final completion:** 2020-07-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-10-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04356534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04356534, "Convalescent Plasma Trial in COVID -19 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04356534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*